Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Motzer

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Journal of the National Cancer Institute|November 18, 1992
High-dose chemotherapy for resistant germ cell tumors: recent advances and future directionsR J Motzer, G J Bosl
The Urologic Clinics of North America|February 1, 1993
Role of adjuvant chemotherapy in patients with stage II nonseminomatous germ-cell tumorsR J Motzer, G J Bosl
The New England Journal of Medicine|July 24, 1997
Testicular germ-cell cancerG J Bosl, R J Motzer
Seminars in Oncology|April 30, 1998
Poor prognosis germ cell tumors: current status and future directionsG C Toner, R J Motzer
The Urologic Clinics of North America|May 1, 1987
Chemotherapy for germ cell tumorsR J Motzer, G J Bosl
Cancer Investigation|January 1, 1993
The current status of salvage chemotherapy for patients with cisplatin-resistant germ cell tumorsR J Motzer, G J Bosl
Urology|August 1, 1987
Hemorrhage: a complication of metastatic testicular choriocarcinomaR J Motzer, G J Bosl
Oncology (Williston Park, N.Y.)|February 19, 2000
Management of renal cell carcinomaJ D Wolchok, R J Motzer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Defining new standards for adjuvant therapy of testis cancer: a replyR J Motzer, J Sheinfeld, H Herr
Surgical Oncology Clinics of North America|October 6, 1997
Adjuvant chemotherapy for testicular cancerH Xiao, J Sheinfeld, R J Motzer
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Journal of the National Cancer Institute|November 18, 1992
High-dose chemotherapy for resistant germ cell tumors: recent advances and future directionsR J Motzer, G J Bosl
The Urologic Clinics of North America|February 1, 1993
Role of adjuvant chemotherapy in patients with stage II nonseminomatous germ-cell tumorsR J Motzer, G J Bosl
The New England Journal of Medicine|July 24, 1997
Testicular germ-cell cancerG J Bosl, R J Motzer
Seminars in Oncology|April 30, 1998
Poor prognosis germ cell tumors: current status and future directionsG C Toner, R J Motzer
The Urologic Clinics of North America|May 1, 1987
Chemotherapy for germ cell tumorsR J Motzer, G J Bosl
Cancer Investigation|January 1, 1993
The current status of salvage chemotherapy for patients with cisplatin-resistant germ cell tumorsR J Motzer, G J Bosl
Urology|August 1, 1987
Hemorrhage: a complication of metastatic testicular choriocarcinomaR J Motzer, G J Bosl
Oncology (Williston Park, N.Y.)|February 19, 2000
Management of renal cell carcinomaJ D Wolchok, R J Motzer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Defining new standards for adjuvant therapy of testis cancer: a replyR J Motzer, J Sheinfeld, H Herr
Surgical Oncology Clinics of North America|October 6, 1997
Adjuvant chemotherapy for testicular cancerH Xiao, J Sheinfeld, R J Motzer
Pageof 16